Health Library
February 15, 2026
Question on this topic? Get an instant answer from August.
Ubuyezi obunconywayo betirzepatide ekuphathweni kwesisindo bungama-5 mg, 10 mg, noma 15 mg kanye ngesonto, kuya ngokuthi umzimba wakho uphendula kanjani emithini nokuthi uwubekezelela kangakanani. Ngemuva kokuba ufinyelele umgomo wakho wokwehlisa isisindo, ucwaningo lubonisa kakhulu ukuthi ukuhlala uthatha umuthi ngomthamo osebenzayo kubalulekile ukugcina isisindo singabuyeli. Ukuyeka i-tirzepatide emva kokulahlekelwa isisindo cishe njalo kuholela ekubuyeni okubalulekile.
Lokho cishe akuyona into obuyithemba ukuyizwa. Kodwa ukuqonda ukuthi kungani ukwelashwa okuqhubekayo kubalulekile nokuthi izinketho zakho zibukeka kanjani kungakusiza ukuthi uhlele kusengaphambili futhi usebenze nodokotela wakho ukuthola indlela elingana nempilo yakho kangcono.
I-Tirzepatide isebenza ngokuvula izindlela ezimbili zamahomoni emzimbeni wakho ezibizwa nge-GLP 1 ne-GIP. Lawa mahomoni asiza ukulawula ukulamba kwakho, anciphise isivinini sokudla esiphuma esiswini sakho, futhi athuthukise indlela umzimba wakho ophatha ngayo ushukela egazini. Ngenkathi umuthi usebenza, unciphisa ukulamba, kukusiza ukuthi uzizwe usuthi ngokudla okuncane, futhi usekele imetabolism yakho.
Kodwa i-tirzepatide ayisethi kabusha unomphela indlela umzimba wakho olawula ngayo isisindo. Uma uyeka umuthi, lawo mahomoni okuhlaba ukulamba abuyela emuva, ukulamba kwakho kwanda, futhi imetabolism yakho ingancipha njengoba umzimba wakho uzama ukubuyela esisindweni sakho sangaphambili. Lokhu akuyona inkinga yokuzimisela. Kuyibhayoloji. Umzimba wakho unohlelo lokuzivikela olwakhelwe ukubuyisa isisindo esilahlekile, futhi ngaphandle kokwesekwa okuqhubekayo, lezi zinhlelo zivame ukuwina.
Ubufakazi obuqine kakhulu buvela ocwaningweni olukhulu lwezivivinyo ezibizwa nge-SURMOUNT 4. Kulesi sifundo, abahlanganyeli bathatha i-tirzepatide ngomthamo wabo omkhulu abawubekezelekayo (10 mg noma 15 mg masonto onke) isikhathi esingama-36 amasonto futhi balahlekelwa ngesilinganiso esingu-21% wesisindo sabo. Lokho kungumphumela omangalisayo.
Ngemva kwalezo zinsuku ezingu-36, ingxenye yeqembu yaqhubeka ne-tirzepatide kanti enye ingxenye yashintshela ku-placebo injection. Imiphumela emavikini angu-52 alandelayo yaba nemangalisa. Abantu baqhubeka nokuthatha umuthi balahlekelwa enye i-5.5% wesisindo sabo. Kodwa labo abayekile ukuthatha umuthi babuyise isilinganiso esingu-14% wesisindo sabo kulesi sikhathi esifanayo.
Okubaluleke nakakhulu, abahlanganyeli abahlala ku-tirzepatide babenethuba elikhulu lokuphatha okungenani u-80% wokulahlekelwa kwabo kokuqala kwesisindo. Abantu abashintshela ku-placebo balahlekelwa cishe yizo zonke lezi zinzuzo naphezu kokuthola ukwelulekwa okunomsoco nokwesekwa kwezindlela zokuphila.
[IMG:https://assets.getbeyondhealth.com/health-lib/blogs/manual_upload_20260216014526_tirzepatide-maintance-dose.png]
Ubuyezi bakho bungumthamo wamasonto onke ozinzile ogcina isisindo singabuyeli emuva ngenkathi ubhekana nawe esikhathini eside. Akuhlale kungokufanayo nomthamo wakho omkhulu phakathi nesigaba sokuqothuka emzimbeni. Udokotela wakho uzosebenza nawe ukuthola izinga elifanele.
Nansi indlela imithamo ejwayele ukuhlukana ngayo:
Ubuyezi bakho obuhle buya ngakwezinto eziningana: ukuthi ulahlekelwe yimalini, ukuthi ukulamba kwakho kusebenza kanjani, yiziphi izimpawu ezivela eceleni ozitholayo, nokuthi impilo yakho iyonke ibukeka kanjani. Abanye abantu benza kahle ku-5 mg esikhathini eside. Abanye badinga i-10 mg noma i-15 mg ukugcina ukulamba nokubuyela kwesisindo kungekho.
Abaningi abantu kanye nodokotela banentshisekelo yokuthi ngabe ukunciphisa umthamo kungasagcina yini imiphumela ngenkathi kunciphisa izimpawu ezivela eceleni nezindleko.
Kunocwaningo oluqhubekayo olubizwa nge-SURMOUNT MAINTAIN olucwaninga ngale mbuzo ngqo. Luqhathanisa ukuqhubeka nomthamo omkhulu obekezelekayo ngokunciphisa ukuya ku-5 mg masonto onke nokushintshela ku-placebo. Imiphumela kulindeleke cishe maphakathi no-2026 futhi izosinika isiqondiso esicace kakhulu.
Okwamanje, abanye odokotela sebevele bavivinya izindlela zokunciphisa emtholampilo. Abanye abantu baye bagcina isisindo sabo ngemithamo ephansi njenge-2.5 mg kuya ku-5 mg enikezwa njalo ngeyodwa noma ezimbili amasonto. Kodwa lokhu kuyenziwa ngamunye futhi kwenziwa ngaphansi kokuqondisa kwezokwelapha. Akuyona into okufanele uzame ngayo wedwa, ngoba ukunciphisa kakhulu noma kude kakhulu kungabangela ukubuyela okusheshayo.
Kungaba njalo, kodwa akufanele kube njalo kuwo wonke umuntu. Ukuvuvukala komzimba kubonakala kakhulu njengesimo esingapheli esivame ukudinga ukuphathwa okuqhubekayo, okufana nomfutho wegazi ophezulu noma isifo sikashukela. Kwabaningi abantu, ukuhlala ku-tirzepatide esikhathini eside yindlela ephumelela kakhulu yokugcina imiphumela yabo.
Ngalokho kusho, abanye abantu bayakwazi ukudlulisela emgqeni ngemuva kokubeka imikhuba eqinile yokuphila ezungeze ukudla okunomsoco, ukuzivocavoca, nokwesekwa kwezokuziphatha. Lokhu kusebenza kangcono lapho ukunciphisa kuyi-gradual, kuqondiswa ngudokotela, futhi kusekelwa uhlelo olubanzi oludlula imithi kuphela.
Into ebalulekile ukuba nale ngxoxo uvulelekile nodokotela wakho esikhundleni sokuyeka wedwa. Ukuyeka ngokuzumayo kuholela emiphumeleni emibi kucwaningo lonke esinalo.
Izivivinyo zezokwelapha zafaka ukwelulekwa kwezindlela zokuphila kanye nomuthi, okuhlanganisa nesikhombisi sendlela yokugcina ukwehla kwamakhilojuli angu-500 ngosuku nokuzivocavoca okungenani imizuzu eyi-150 isonto ngalinye.
Ukubeka imikhuba ezungeze ukudla okunomsoco, ukunyakaza okuvamile, ukulala ngokwanele, nokuphatha ukucindezeleka konke kusiza ukusekela lokho umuthi okwenzayo. Le mikhuba futhi ikunikeza ithuba elihle kakhulu lokuphatha imiphumela uma uke wanciphisa umthamo wakho noma wadlulisela emgqeni.
Uma ufinyelele umgomo wakho wokulahlekelwa isisindo futhi uzibuza ukuthi yini elandelayo, leso yisikhathi esihle kakhulu sokukukhuluma ngaso. Buza ukuthi ngumthamo opheleleini ofanele wena, ukuthi ngabe ukunciphisa kuyokwenzeka yini, nokuthi uhlelo lwakho kufanele lubukeke kanjani unyaka ozayo. Uba ngumuntu ohamba phambili ekuhleleni ukuphathwa, imiphumela yakho yesikhathi eside izoba ngcono.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.